Luis J. Leandro‐García

Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma

Iñaki Comino‐Méndez, Francisco Javier Gracia-Aznárez, Francesca Schiavi et al. · Nature Genetics · 2011 · 527 citations · Full text

Life Sciences, Genetics, Molecular Genetics +14

Tumoral and tissue‐specific expression of the major human β‐tubulin isotypes

Luis J. Leandro‐García, Susanna Leskelä, Iñigo Landa et al. · Cytoskeleton · 2010 · 268 citations

Medicine, Molecular Biology, Oncology +13

Single nucleotide polymorphism associations with response and toxic effects in patients with advanced renal-cell carcinoma treated with first-line sunitinib: a multicentre, observational, prospective study

Jesús García-Donás, Emilio Esteban, Luis J. Leandro‐García et al. · The Lancet Oncology · 2011 · 220 citations

Medicine, Oncology, Pharmacology +13

Research Resource: Transcriptional Profiling Reveals Different Pseudohypoxic Signatures in SDHB and VHL-Related Pheochromocytomas

Elena López‐Jiménez, Gonzalo Goméz-López, Luis J. Leandro‐García et al. · Molecular Endocrinology · 2010 · 211 citations · Full text

Life Sciences, Genetics, Molecular Biology +16

The miR-200 family controls  -tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients

Susanna Leskelä, Luis J. Leandro‐García, Marta Mendiola et al. · Endocrine Related Cancer · 2010 · 207 citations · Full text

Medicine, Molecular Medicine, Oncology +17